Romano Danesi


Ontology type: schema:Person     


Person Info

NAME

Romano

SURNAME

Danesi

Publications in SciGraph latest 50 shown

  • 2018-12 Radiomics and liquid biopsy in oncology: the holons of systems medicine in INSIGHTS INTO IMAGING
  • 2018-12 The use of intravenous versus subcutaneous monoclonal antibodies in the treatment of severe asthma: a review in RESPIRATORY RESEARCH
  • 2018-11 The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response in BRITISH JOURNAL OF CANCER
  • 2018-06 Clinical pharmacology of intravitreal anti-VEGF drugs in EYE
  • 2018-04 Phosphorylation of AKT and ERK1/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2018-03-20 PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC in BRITISH JOURNAL OF CANCER
  • 2018-02 Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-Chemotherapy in MOLECULAR NEUROBIOLOGY
  • 2017-12 Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer in SCIENTIFIC REPORTS
  • 2017-04 The Language of Biosimilars: Clarification, Definitions, and Regulatory Aspects in DRUGS
  • 2017-04 Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2017-03 Unusual gastrointestinal and cutaneous toxicities by bleomycin, etoposide, and cisplatin: a case report with pharmacogenetic analysis to personalize treatment in EPMA JOURNAL
  • 2017 Pharmacogenetics and Personalized Medicine in DRUG DESIGN: PRINCIPLES AND APPLICATIONS
  • 2016-12 Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients in INVESTIGATIONAL NEW DRUGS
  • 2016-07 Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2016-05 EPMA-World Congress 2015 in EPMA JOURNAL
  • 2016 The Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: An Overview in RESISTANCE TO TYROSINE KINASE INHIBITORS
  • 2015-12 Discovery of novel mutations in the dihydropyrimidine dehydrogenase gene associated with toxicity of fluoropyrimidines and viewpoint on preemptive pharmacogenetic screening in patients in EPMA JOURNAL
  • 2015-12 EPMA position paper in cancer: current overview and future perspectives in EPMA JOURNAL
  • 2015-12 Molecular and pathological characterization of the EZH2 rs3757441 single nucleotide polymorphism in colorectal cancer in BMC CANCER
  • 2015-10 Comment on “High expression of CD39/ENTPD1 in malignant epithelial cells of human rectal adenocarcinoma” in TUMOR BIOLOGY
  • 2014-09 EGFR ligands as pharmacodynamic biomarkers in metastatic colorectal cancer patients treated with cetuximab and irinotecan in TARGETED ONCOLOGY
  • 2014-08 The c.480C>G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemia in THE PHARMACOGENOMICS JOURNAL
  • 2014-02 A clinical pharmacogenetic characterization of DPD polymorphisms for pre-treatment screening of patients candidates to fluoropyrimidine therapy in EPMA JOURNAL
  • 2014-02 Detection of KRAS mutant alleles in circulating cell-free tumor DNA in colorectal cancer patients resistant to cetuximab in EPMA JOURNAL
  • 2013-08 VEGF-A polymorphisms predict progression-free survival among advanced castration-resistant prostate cancer patients treated with metronomic cyclophosphamide in BRITISH JOURNAL OF CANCER
  • 2013-07 The pharmacological bases of the antiangiogenic activity of paclitaxel in ANGIOGENESIS
  • 2013-07 Clinical Pharmacokinetics of Antibacterials in Cerebrospinal Fluid in CLINICAL PHARMACOKINETICS
  • 2012-12 The emerging role of histone lysine demethylases in prostate cancer in MOLECULAR CANCER
  • 2012-12 EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis in CANCER AND METASTASIS REVIEWS
  • 2012-08 First-line metronomic chemotherapy in a metastatic model of spontaneous canine tumours: a pilot study in INVESTIGATIONAL NEW DRUGS
  • 2012-06 Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers in ANGIOGENESIS
  • 2011-12 Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer in MOLECULAR CANCER
  • 2011-07-25 C11 Cytotoxic drugs in PRINCIPLES OF IMMUNOPHARMACOLOGY
  • 2011-06 Promoting predictive, preventive and personalised medicine: European event of global importance in EPMA JOURNAL
  • 2011-04 Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line FOLFOXIRI plus bevacizumab schedule in metastatic colorectal cancer in BRITISH JOURNAL OF CANCER
  • 2010-12 Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib in JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
  • 2010-12 Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC) patients in BMC CANCER
  • 2010-09 Dihydropyrimidine dehydrogenase polymorphisms and fluoropyrimidine toxicity: ready for routine clinical application within personalized medicine? in EPMA JOURNAL
  • 2010-09 Metronomic Chemotherapy for Metastatic Prostate Cancer in DRUGS & AGING
  • 2010-08 Cellular and molecular mechanisms for the synergistic cytotoxicity elicited by oxaliplatin and pemetrexed in colon cancer cell lines in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2010-07 Pharmacological Issues of Linezolid in CLINICAL PHARMACOKINETICS
  • 2010-06 Expression of gemcitabine- and cisplatin-related genes in non-small-cell lung cancer in THE PHARMACOGENOMICS JOURNAL
  • 2010-03 Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2010 Pharmacogenetics of Angiogenesis in DRUG MANAGEMENT OF PROSTATE CANCER
  • 2008-07 Laser microdissection and primary cell cultures improve pharmacogenetic analysis in pancreatic adenocarcinoma in LABORATORY INVESTIGATION
  • 2008-05 Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib in BRITISH JOURNAL OF CANCER
  • 2008-04 A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients in BRITISH JOURNAL OF CANCER
  • 2008 Pharmacogenetics of Antiangiogenic Therapy in ANGIOGENESIS
  • 2006-11 Irinotecan in combination with thalidomide in patients with advanced solid tumors: a clinical study with pharmacodynamic and pharmacokinetic evaluation in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2006-10 A pharmacokinetic‐based test to prevent severe 5‐fluorouracil toxicity in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.5395.a", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.6530.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.263145.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.48336.3a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.15667.33", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.415079.e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.18147.3b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.94365.3d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.410345.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.8404.8", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.27755.32", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.488566.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5608.b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.9027.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.16872.3a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.7605.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.144189.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5133.4", 
            "type": "Organization"
          }
        ], 
        "familyName": "Danesi", 
        "givenName": "Romano", 
        "id": "sg:person.0704167507.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704167507.01"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:50", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_560.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0704167507.01'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0704167507.01'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0704167507.01'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0704167507.01'


     

    This table displays all metadata directly associated to this object as RDF triples.

    50 TRIPLES      10 PREDICATES      28 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.0704167507.01 schema:affiliation Nc00bf905a956463bad5b89d1273ff81e
    2 https://www.grid.ac/institutes/grid.144189.1
    3 https://www.grid.ac/institutes/grid.15667.33
    4 https://www.grid.ac/institutes/grid.16872.3a
    5 https://www.grid.ac/institutes/grid.18147.3b
    6 https://www.grid.ac/institutes/grid.263145.7
    7 https://www.grid.ac/institutes/grid.27755.32
    8 https://www.grid.ac/institutes/grid.410345.7
    9 https://www.grid.ac/institutes/grid.415079.e
    10 https://www.grid.ac/institutes/grid.48336.3a
    11 https://www.grid.ac/institutes/grid.488566.1
    12 https://www.grid.ac/institutes/grid.5133.4
    13 https://www.grid.ac/institutes/grid.5608.b
    14 https://www.grid.ac/institutes/grid.6530.0
    15 https://www.grid.ac/institutes/grid.7605.4
    16 https://www.grid.ac/institutes/grid.8404.8
    17 https://www.grid.ac/institutes/grid.9027.c
    18 https://www.grid.ac/institutes/grid.94365.3d
    19 schema:familyName Danesi
    20 schema:givenName Romano
    21 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704167507.01
    22 schema:sdDatePublished 2019-03-07T14:50
    23 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    24 schema:sdPublisher N9cd281eec8f14e66a80aa8b04172d551
    25 sgo:license sg:explorer/license/
    26 sgo:sdDataset persons
    27 rdf:type schema:Person
    28 N9cd281eec8f14e66a80aa8b04172d551 schema:name Springer Nature - SN SciGraph project
    29 rdf:type schema:Organization
    30 Nc00bf905a956463bad5b89d1273ff81e schema:affiliation https://www.grid.ac/institutes/grid.5395.a
    31 sgo:isCurrent true
    32 rdf:type schema:OrganizationRole
    33 https://www.grid.ac/institutes/grid.144189.1 schema:Organization
    34 https://www.grid.ac/institutes/grid.15667.33 schema:Organization
    35 https://www.grid.ac/institutes/grid.16872.3a schema:Organization
    36 https://www.grid.ac/institutes/grid.18147.3b schema:Organization
    37 https://www.grid.ac/institutes/grid.263145.7 schema:Organization
    38 https://www.grid.ac/institutes/grid.27755.32 schema:Organization
    39 https://www.grid.ac/institutes/grid.410345.7 schema:Organization
    40 https://www.grid.ac/institutes/grid.415079.e schema:Organization
    41 https://www.grid.ac/institutes/grid.48336.3a schema:Organization
    42 https://www.grid.ac/institutes/grid.488566.1 schema:Organization
    43 https://www.grid.ac/institutes/grid.5133.4 schema:Organization
    44 https://www.grid.ac/institutes/grid.5395.a schema:Organization
    45 https://www.grid.ac/institutes/grid.5608.b schema:Organization
    46 https://www.grid.ac/institutes/grid.6530.0 schema:Organization
    47 https://www.grid.ac/institutes/grid.7605.4 schema:Organization
    48 https://www.grid.ac/institutes/grid.8404.8 schema:Organization
    49 https://www.grid.ac/institutes/grid.9027.c schema:Organization
    50 https://www.grid.ac/institutes/grid.94365.3d schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...